|
US7790699B2
(en)
|
2004-10-12 |
2010-09-07 |
Fmc Biopolymer As |
Self-gelling alginate systems and uses thereof
|
|
AU2006275595B2
(en)
|
2005-07-29 |
2012-08-16 |
Concert Pharmaceuticals Inc. |
Novel benzo [d] [1,3]-dioxol derivatives
|
|
US8796267B2
(en)
|
2006-10-23 |
2014-08-05 |
Concert Pharmaceuticals, Inc. |
Oxazolidinone derivatives and methods of use
|
|
US8071596B2
(en)
|
2007-01-12 |
2011-12-06 |
Concert Pharmaceuticals, Inc. |
Endothelin receptor antagonists
|
|
US8080549B2
(en)
|
2007-01-12 |
2011-12-20 |
Concert Pharmaceuticals, Inc. |
Endothelin receptor antagonists
|
|
US8013007B2
(en)
|
2007-02-26 |
2011-09-06 |
Concert Pharmaceuticals, Inc. |
Alpha 1A-adrenoceptor antagonists
|
|
ES2395241T3
(es)
|
2007-03-07 |
2013-02-11 |
Concert Pharmaceuticals Inc. |
Derivados deuterados de piperazina como compuestos antianginosos
|
|
US8759383B2
(en)
|
2007-03-16 |
2014-06-24 |
Concert Pharmaceuticals, Inc. |
Inhibitors of cholesterol ester transfer protein
|
|
WO2008128166A1
(en)
|
2007-04-13 |
2008-10-23 |
Concert Pharmaceuticals Inc. |
Deuterated derivatives of 4-(6-fluoro-1, 2-benzisoxazol-3-yl) piperidine compounds
|
|
US8349817B2
(en)
|
2007-04-25 |
2013-01-08 |
Concert Pharmaceuticals, Inc. |
Analogues of cilostazol
|
|
EP2527336A1
(en)
|
2007-04-25 |
2012-11-28 |
Concert Pharmaceuticals Inc. |
Deuterated analogues of cilostazol
|
|
PT2522668E
(pt)
|
2007-05-01 |
2015-06-09 |
Concert Pharmaceuticals Inc |
Compostos de morfinano
|
|
CN102718710B
(zh)
|
2007-05-01 |
2014-11-05 |
康塞特医药品公司 |
吗啡烷化合物
|
|
US7820666B2
(en)
|
2007-05-08 |
2010-10-26 |
Concert Pharmaceuticals, Inc. |
Tetrahydrotriazolopyrazine derivatives and uses thereof
|
|
DE602008000255D1
(de)
|
2007-06-12 |
2009-12-17 |
Concert Pharmaceuticals Inc |
Azapeptid-Derivate als HIV-Protease-Inhibitoren
|
|
US7687509B2
(en)
|
2007-07-09 |
2010-03-30 |
Concert Pharmaceuticals Inc. |
Pyrimidinecarboxamide derivatives
|
|
EP2190841B1
(en)
|
2007-08-14 |
2013-05-15 |
Concert Pharmaceuticals Inc. |
Substituted oxazolidinone derivatives
|
|
BRPI0815977A2
(pt)
|
2007-08-28 |
2017-06-13 |
Fmc Corp |
dispersão, kit e composição para fabricar a mesma, métodos para dispensar uma dispersão de alginato auto-geleificante retardada, para preparar um gel de alginato e para preparar alginato insolúvel/ partículas de íon geleificante, e, alginato ultrapuro insolúvel/partículas de íon geleificante.
|
|
EP2197847B1
(en)
|
2007-09-12 |
2012-11-07 |
Concert Pharmaceuticals Inc. |
Deuterated 4 -oxoquinoline derivative for the treatment of hiv infection
|
|
JP5647519B2
(ja)
|
2007-09-13 |
2014-12-24 |
コンサート ファーマシューティカルズ インコーポレイテッド |
重水素化カテコールおよびベンゾ[d][1,3]ジオキソールおよびその誘導体の合成
|
|
EP2212298B1
(en)
|
2007-10-18 |
2013-03-27 |
Concert Pharmaceuticals Inc. |
Deuterated etravirine
|
|
US8592487B2
(en)
|
2007-10-26 |
2013-11-26 |
Concert Pharmaceuticals, Inc. |
Deuterated darunavir
|
|
EP2231155A4
(en)
|
2007-12-18 |
2011-09-14 |
Concert Pharmaceuticals Inc |
Tetrahydroisoquinoline DERIVATIVES
|
|
WO2009094216A1
(en)
|
2008-01-22 |
2009-07-30 |
Concert Pharmaceuticals Inc. |
Derivatives of gefitinib
|
|
WO2009094210A1
(en)
|
2008-01-22 |
2009-07-30 |
Concert Pharmaceuticals Inc. |
Vandetanib derivatives
|
|
WO2009108383A2
(en)
|
2008-02-29 |
2009-09-03 |
Concert Pharmaceuticals, Inc. |
Substituted xanthine derivatives
|
|
US8367674B2
(en)
|
2008-04-17 |
2013-02-05 |
Concert Pharmaceuticals, Inc. |
Piperazine derivatives
|
|
US8354557B2
(en)
|
2008-06-17 |
2013-01-15 |
Concert Pharmaceuticals, Inc. |
Synthesis of deuterated morpholine derivatives
|
|
MX2011002278A
(es)
|
2008-08-29 |
2011-04-14 |
Concert Pharmaceuticals Inc |
Derivados de triazolo-piridazina sustituidos.
|
|
EP2334621A1
(en)
|
2008-09-16 |
2011-06-22 |
Concert Pharmaceuticals, Inc. |
Deuterated 2-amino-3-hydroxypropanoic acid derivatives
|
|
ES2575086T3
(es)
|
2008-09-19 |
2016-06-24 |
Concert Pharmaceuticals Inc. |
Compuestos de morfinano deuterados
|
|
US9045453B2
(en)
|
2008-11-14 |
2015-06-02 |
Concert Pharmaceuticals, Inc. |
Substituted dioxopiperidinyl phthalimide derivatives
|
|
SG173758A1
(en)
*
|
2009-02-24 |
2011-09-29 |
Novartis Ag |
Uses of nk receptor antagonists
|
|
US8263601B2
(en)
|
2009-02-27 |
2012-09-11 |
Concert Pharmaceuticals, Inc. |
Deuterium substituted xanthine derivatives
|
|
DE102009001446A1
(de)
|
2009-03-10 |
2010-09-23 |
Evonik Rohmax Additives Gmbh |
Verwendung von Kammpolymeren als Antifatigue-Additive
|
|
US8563554B2
(en)
|
2009-03-17 |
2013-10-22 |
Concert Pharmaceuticals, Inc. |
Deuterated pyrazinoisoquinoline compounds
|
|
WO2010108103A1
(en)
*
|
2009-03-19 |
2010-09-23 |
Concert Pharmaceuticals, Inc. |
Azepan-2-one derivatives
|
|
WO2010124046A1
(en)
|
2009-04-23 |
2010-10-28 |
Concert Pharmaceuticals, Inc. |
4-hydroxybutyric acid analogs
|
|
US8410082B2
(en)
|
2009-05-22 |
2013-04-02 |
Concert Pharmaceuticals, Inc. |
Fluorinated diaryl urea derivatives
|
|
HRP20140520T1
(hr)
|
2009-06-18 |
2014-07-04 |
Concert Pharmaceuticals Inc. |
Deuterirani derivati izoindolin-1,3-diona kao inhibitori pde4 i tnf-alfa
|
|
JP2012531419A
(ja)
|
2009-06-23 |
2012-12-10 |
コンサート ファーマシューティカルズ インコーポレイテッド |
Gaba−a受容体修飾物質としての重水素修飾されたトリアゾロピリダジン誘導体
|
|
WO2011020044A1
(en)
|
2009-08-14 |
2011-02-17 |
Concert Pharmaceuticals, Inc. |
Substituted triazolophthalazine derivatives
|
|
WO2011028835A1
(en)
|
2009-09-02 |
2011-03-10 |
Concert Pharmaceuticals, Inc. |
Substituted xanthine derivatives
|
|
US9260432B2
(en)
|
2009-09-02 |
2016-02-16 |
Concert Pharmaceuticals, Inc. |
Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
|
|
WO2011047315A1
(en)
|
2009-10-15 |
2011-04-21 |
Concert Pharmaceuticals, Inc. |
Subsitituted benzimidazoles
|
|
US8471034B2
(en)
|
2009-11-18 |
2013-06-25 |
Concert Pharmaceuticals, Inc. |
Niacin prodrugs and deuterated versions thereof
|
|
DE102010001040A1
(de)
|
2010-01-20 |
2011-07-21 |
Evonik RohMax Additives GmbH, 64293 |
(Meth)acrylat-Polymere zur Verbesserung des Viskositätsindexes
|
|
US8575361B2
(en)
|
2010-03-02 |
2013-11-05 |
Concert Pharmaceuticals Inc. |
Tetrahydronaphthalene derivatives
|
|
WO2011109464A1
(en)
|
2010-03-02 |
2011-09-09 |
Concert Pharmaceuticals Inc. |
Deuterated tetrahydronaphthalene derivatives
|
|
US9226801B2
(en)
*
|
2010-03-08 |
2016-01-05 |
Ibur, Llc |
Custom linkable imaging and multifunctional tray
|
|
WO2011116066A1
(en)
|
2010-03-17 |
2011-09-22 |
Concert Pharmaceuticals, Inc. |
Derivatives of dimethylcurcumin
|
|
US9107922B2
(en)
|
2010-07-16 |
2015-08-18 |
Concert Pharmaceuticals, Inc. |
Pyrimidinecarboxamide derivatives
|
|
WO2012031072A1
(en)
|
2010-09-01 |
2012-03-08 |
Concert Pharmaceuticals, Inc. |
Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
|
|
WO2012031073A1
(en)
|
2010-09-01 |
2012-03-08 |
Concert Pharmaceuticals, Inc. |
Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
|
|
CN103370289B
(zh)
|
2011-02-14 |
2015-09-09 |
康塞特医药品有限公司 |
4-羟基丁酸氘化类似物
|
|
US9145390B2
(en)
|
2011-03-03 |
2015-09-29 |
Concert Pharmaceuticals, Inc. |
Derivatives of pyrazole-substituted amino-heteroaryl compounds
|
|
US8889687B2
(en)
|
2011-03-04 |
2014-11-18 |
Concert Pharmaceuticals, Inc. |
Deuterated pyrazinoisoquinoline compounds
|
|
HUE047354T2
(hu)
|
2011-05-18 |
2020-04-28 |
Vertex Pharmaceuticals Europe Ltd |
Ivacaftor deuterizált származékai
|
|
MX2014012384A
(es)
|
2012-04-13 |
2014-11-26 |
Concert Pharmaceuticals Inc |
Derivados sustituidos de xantina.
|
|
EP2838879A1
(en)
|
2012-04-20 |
2015-02-25 |
Concert Pharmaceuticals Inc. |
Deuterated rigosertib
|
|
CA2876306C
(en)
|
2012-06-15 |
2024-02-20 |
Concert Pharmaceuticals, Inc. |
Deuterated derivatives of ruxolitinib
|
|
US9181190B2
(en)
|
2012-07-04 |
2015-11-10 |
Concert Pharmaceuticals, Inc. |
Deuterated vercirnon
|
|
ES2694202T3
(es)
|
2012-07-12 |
2018-12-19 |
Concert Pharmaceuticals, Inc. |
Idebenona deuterada
|
|
CA2879400A1
(en)
|
2012-07-30 |
2014-02-06 |
Concert Pharmaceuticals, Inc. |
Deuterated ibrutinib
|
|
EA031716B1
(ru)
|
2012-08-17 |
2019-02-28 |
Консерт Фармасьютикалс, Инк. |
Дейтерированный барицитиниб
|
|
WO2014066243A1
(en)
|
2012-10-22 |
2014-05-01 |
Concert Pharmaceuticals, Inc. |
Solid forms of {s-3-(4-amino-1-oxo-isoindolin-2yl)(piperidine-3,4,4,5,5-d5)-2,6-dione}
|
|
WO2014110189A1
(en)
|
2013-01-09 |
2014-07-17 |
Concert Pharmaceuticals Inc. |
Deuterated momelotinib
|
|
EP2968268B1
(en)
|
2013-03-15 |
2020-07-29 |
Concert Pharmaceuticals Inc. |
Inhibitors of the enzyme udp-glucose: n-acyl-sphingosine glucosyltransferase
|
|
US8906951B1
(en)
|
2013-06-24 |
2014-12-09 |
Tigercat Pharma, Inc. |
Use of NK-1 receptor antagonists in pruritus
|
|
US9198898B2
(en)
|
2013-06-24 |
2015-12-01 |
Tigercat Pharma, Inc. |
Use of NK-1 receptor antagonists in pruritus
|
|
US9676790B2
(en)
|
2013-08-30 |
2017-06-13 |
Concert Pharmaceuticals, Inc. |
Substituted thienotriazolodiazapines
|
|
US9694017B2
(en)
|
2014-02-10 |
2017-07-04 |
Concert Pharmaceuticals, Inc. |
Substituted triazolobenzodiazepines
|
|
US10160778B2
(en)
|
2014-10-27 |
2018-12-25 |
Concert Pharmaceuticals, Inc. |
Pyrimidine phosphonic acid esters
|
|
WO2016160945A1
(en)
|
2015-03-31 |
2016-10-06 |
Concert Pharmaceuticals, Inc. |
Deuterated vx-661
|
|
US10683305B2
(en)
|
2015-04-27 |
2020-06-16 |
Concert Pharmaceuticals, Inc. |
Deuterated OTX-015
|
|
AU2016327603B2
(en)
|
2015-09-25 |
2021-04-22 |
Vertex Pharmaceuticals (Europe) Limited |
Deuterated CFTR potentiators
|
|
US11267777B2
(en)
|
2015-11-19 |
2022-03-08 |
Concert Pharmaceuticals, Inc. |
Deuterated EPI-743
|
|
EP3416629A4
(en)
|
2016-02-16 |
2019-08-07 |
CoNCERT Pharmaceuticals, Inc. |
DEUTERATED GFT-505
|
|
IL322463A
(en)
|
2017-11-22 |
2025-09-01 |
Sun Pharmaceutical Ind Inc |
Deuterated d-serine analogs and their uses
|
|
HRP20241608T1
(hr)
|
2017-12-01 |
2025-01-31 |
Vertex Pharmaceuticals Incorporated |
Postupci za proizvodnju modulatora transmembranskog regulatora provodljivosti cistične fibroze
|
|
US12065395B2
(en)
|
2019-04-03 |
2024-08-20 |
Sun Pharmaceutical Industries, Inc. |
Processes for the preparation of deuterated D-serine
|